ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2257

Regulation of Mitochondrial Proton Gradient Is Critical for NLRP3 Inflammasome Activation

Jehad H. Edwan, Raphaela Goldbach-Mansky and Robert A. Colbert, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Autoinflammation, inflammasome activation, Inflammation, mitochondria and monocytes

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Innate Immunity and Rheumatic Disease - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  Self-activating mutations in NLRP3 cause a spectrum of autoinflammatory diseases known as cryopyrin-associated periodic syndromes (CAPS). NLRP3 is a key component of a multiprotein complex known as the inflammasome that mediates the maturation of the proinflammatory cytokine IL-1β, and can induce rapid cell death in a process known as pyronecrosis. Although several models for inflammasome activation have been proposed the precise molecular mechanism, as well as the role of NRLP3 mutations, remains to be elucidated. Emerging evidence suggests that mitochondria are involved in inflammasome activation. ATP is produced from ADP in the presence of a proton gradient across the mitochondrial membrane by ATP synthase (F(1)F(0) ATP synthase). F-type ATPases consist of two structural domains, F(1) – containing the extramembraneous catalytic core, and F(0) – containing the membrane proton channel. ATP5O appears to be part of the connector linking these two components and it confers sensitivity to oligomycin induced increase in the proton gradient. Here we asked whether regulation of mitochondrial membrane potential by ATP50 and oligomycin plays a role in NLRP3 inflammasome activation.

Methods: ATP5O expression was knocked down in THP-1 cells. Cells were stimulated with LPS followed by oligomycin and ATP. IL-1β release and intracellular IL-1β were measured with a flow-based assay. Supernatants were incubated with IL-1β-capture beads, added back to fixed and permeabilized cells, and both were stained with antibodies against IL-1β, then evaluated by flow cytometry. Viability of non-fixed cells was evaluated with 7AAD staining. LPS stimulated cells were also evaluated by immunofluorescence and western blot analysis.

Results:  By flow analysis we provide evidence that an increase in the proton gradient induced by oligomycin results in a significant increase in ATP induced inflammasome activation, while knockdown of ATP5O, results in a significant reduction in inflammasome activation. Decreasing the proton gradient with FCCP and 2DG significantly inhibits inflammasome activation, suggesting a requirement for an increased proton gradient across the mitochondrial membrane. Using confocal microscopy of BMDM from NLRP3 knockout mice to visualize pyronecrosis, we provide evidence that this process is NLRP3 dependent. 

Conclusion:  These data suggest a previously unrecognized role for ATP5O in regulating mitochondrial membrane potential, which can regulate NLRP3 inflammasome activation. These results point toward mitochondrial membrane potential as a novel therapeutic target for NLRP3-mediated inflammatory diseases.


Disclosure: J. H. Edwan, None; R. Goldbach-Mansky, None; R. A. Colbert, None.

To cite this abstract in AMA style:

Edwan JH, Goldbach-Mansky R, Colbert RA. Regulation of Mitochondrial Proton Gradient Is Critical for NLRP3 Inflammasome Activation [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/regulation-of-mitochondrial-proton-gradient-is-critical-for-nlrp3-inflammasome-activation/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/regulation-of-mitochondrial-proton-gradient-is-critical-for-nlrp3-inflammasome-activation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology